An Intervention Study to Reduce Drug-related Problems and Readmissions Among Old People With Dementia

Umeå University

Status: Completed

Conditions: Cognitive Impairment

Treatments: Other: Medication review

Study type: Interventional

Funder types: Other

Identifiers

NCT01504672

UmU-2011-148-31M

Details and patient eligibility

About

The aim of this randomized controlled study is to investigate if medication reviews performed by a clinical pharmacist as part of a ward team can reduce drug related problems and reduce readmissions to hospital among elderly patients (≥65 years) with dementia and cognitive failure.

Four hundred and sixty patients will be recruited and randomized to control (usual care) and intervention group (enhanced service in which a pharmacist is part of the health care team).

Six months after the last patient of the 460 has been discharged the study will be closed. Data about the number of readmissions and visits to the emergency room will be collected during the six-month follow-up and also, the costs associated with each visit or admission. Time until institutionalization will be compared between intervention group and control group.

Enrollment: 460 patients

Sex: All

Ages: 65+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients with dementia or cognitive impairment
• Patients ≥ 65 years

Exclusion criteria

• Patients previously admitted to the study wards during the study period

Trial design

Primary purpose: Other

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

460 participants in 2 patient groups

Medication review

Experimental group

Treatment:

Other: Medication review

Usual care

No Intervention group